118 related articles for article (PubMed ID: 27430156)
21. Wilms tumor and the WT1 gene.
Lee SB; Haber DA
Exp Cell Res; 2001 Mar; 264(1):74-99. PubMed ID: 11237525
[TBL] [Abstract][Full Text] [Related]
22. Upregulated WTAP expression in colorectal cancer correlates with tumor site and differentiation.
Dong XF; Wang Y; Tang CH; Huang BF; Du Z; Wang Q; Shao JK; Lu HJ; Wang CQ
PLoS One; 2022; 17(2):e0263749. PubMed ID: 35143566
[TBL] [Abstract][Full Text] [Related]
23. Regulation of insulin-like growth factor I receptor promoter activity by wild-type and mutant versions of the WT1 tumor suppressor.
Tajinda K; Carroll J; Roberts CT
Endocrinology; 1999 Oct; 140(10):4713-24. PubMed ID: 10499530
[TBL] [Abstract][Full Text] [Related]
24. Identification of WTAP-related genes by weighted gene co-expression network analysis in ovarian cancer.
Wang J; Xu J; Li K; Huang Y; Dai Y; Xu C; Kang Y
J Ovarian Res; 2020 Sep; 13(1):119. PubMed ID: 32998774
[TBL] [Abstract][Full Text] [Related]
25. WT1, the Wilms' tumor suppressor gene product, represses transcription through an interactive nuclear protein.
Wang ZY; Qiu QQ; Gurrieri M; Huang J; Deuel TF
Oncogene; 1995 Mar; 10(6):1243-7. PubMed ID: 7700651
[TBL] [Abstract][Full Text] [Related]
26. Integrative genomic analyses on interferon-lambdas and their roles in cancer prediction.
Yang L; Wei J; He S
Int J Mol Med; 2010 Feb; 25(2):299-304. PubMed ID: 20043142
[TBL] [Abstract][Full Text] [Related]
27. Relationship between the genetic expression of WTAP and bladder cancer and patient prognosis.
Chen L; Wang X
Oncol Lett; 2018 Dec; 16(6):6966-6970. PubMed ID: 30546429
[TBL] [Abstract][Full Text] [Related]
28. An interaction proteomics survey of transcription factor binding at recurrent TERT promoter mutations.
Makowski MM; Willems E; Fang J; Choi J; Zhang T; Jansen PW; Brown KM; Vermeulen M
Proteomics; 2016 Feb; 16(3):417-26. PubMed ID: 26553150
[TBL] [Abstract][Full Text] [Related]
29. Novel polymorphisms in UTR and coding region of inducible heat shock protein 70.1 gene in tropically adapted Indian zebu cattle (Bos indicus) and riverine buffalo (Bubalus bubalis).
Sodhi M; Mukesh M; Kishore A; Mishra BP; Kataria RS; Joshi BK
Gene; 2013 Sep; 527(2):606-15. PubMed ID: 23792016
[TBL] [Abstract][Full Text] [Related]
30. BR22, a novel protein, interacts with thyroid transcription factor-1 and activates the human surfactant protein B promoter.
Yang YS; Yang MC; Wang B; Weissler JC
Am J Respir Cell Mol Biol; 2001 Jan; 24(1):30-37. PubMed ID: 11152647
[TBL] [Abstract][Full Text] [Related]
31. Activation of the WT1 tumor suppressor gene promoter by Pea3.
Discenza MT; Vaz D; Hassell JA; Pelletier J
FEBS Lett; 2004 Feb; 560(1-3):183-91. PubMed ID: 14988020
[TBL] [Abstract][Full Text] [Related]
32. Despite WT1 binding sites in the promoter region of human and mouse nucleoporin glycoprotein 210, WT1 does not influence expression of GP210.
Olsson M; English MA; Mason J; Licht JD; Ekblom P
J Negat Results Biomed; 2004 Dec; 3():7. PubMed ID: 15613247
[TBL] [Abstract][Full Text] [Related]
33. Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells.
Katoh M; Katoh M
Int J Mol Med; 2006 Apr; 17(4):681-5. PubMed ID: 16525728
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional activity of testis-determining factor SRY is modulated by the Wilms' tumor 1 gene product, WT1.
Matsuzawa-Watanabe Y; Inoue J; Semba K
Oncogene; 2003 Sep; 22(39):7900-4. PubMed ID: 12970737
[TBL] [Abstract][Full Text] [Related]
35. Physiological functions of Wilms' tumor 1-associating protein and its role in tumourigenesis.
Xie W; Wei L; Guo J; Guo H; Song X; Sheng X
J Cell Biochem; 2019 Jul; 120(7):10884-10892. PubMed ID: 30756410
[TBL] [Abstract][Full Text] [Related]
36. Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.
Cha S; Lee J; Shin JY; Kim JY; Sim SH; Keam B; Kim TM; Kim DW; Heo DS; Lee SH; Kim JI
BMC Cancer; 2016 Feb; 16():170. PubMed ID: 26925973
[TBL] [Abstract][Full Text] [Related]
37. Evolution of vertebrate genes related to prion and Shadoo proteins--clues from comparative genomic analysis.
Premzl M; Gready JE; Jermiin LS; Simonic T; Marshall Graves JA
Mol Biol Evol; 2004 Dec; 21(12):2210-31. PubMed ID: 15342797
[TBL] [Abstract][Full Text] [Related]
38. Regulatory back-up circuit of medaka Wt1 co-orthologs ensures PGC maintenance.
Klüver N; Herpin A; Braasch I; Driessle J; Schartl M
Dev Biol; 2009 Jan; 325(1):179-88. PubMed ID: 18992736
[TBL] [Abstract][Full Text] [Related]
39. Integrative genomic analyses on HES/HEY family: Notch-independent HES1, HES3 transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer.
Katoh M; Katoh M
Int J Oncol; 2007 Aug; 31(2):461-6. PubMed ID: 17611704
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of c-MYC in WT1-mutant tumors: assessment of WT1 putative transcriptional targets using cDNA microarray expression profiling of genetically defined Wilms' tumors.
Udtha M; Lee SJ; Alam R; Coombes K; Huff V
Oncogene; 2003 Jun; 22(24):3821-6. PubMed ID: 12802290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
